Ondine Biomedical Inc. NPV (CDI) (OBI) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 Oct 2024 05:30 PM
RNS
Related Party Transaction
28 Oct 2024 07:00 AM
RNS
Ondine continues commercial growth
23 Oct 2024 07:00 AM
RNS
King’s College Hospital to run Steriwave pilot
18 Oct 2024 07:00 AM
RNS
Steriwave receives UAE Regulatory Approval
30 Sep 2024 07:07 AM
RNS
Ondine Biomedical Reports Robust Growth in H1 2024
25 Sep 2024 07:00 AM
RNS
Collaboration advances Steriwave for ICU Market
24 Sep 2024 07:29 AM
RNS
Ondine secures C$5 million financing
23 Sep 2024 07:00 AM
RNS
Mölnlycke® and Ondine Join Forces Against HAIs
16 Sep 2024 07:00 AM
RNS
Related Party Transaction
16 Sep 2024 07:00 AM
RNS
Ondine announces Board Changes
23 Aug 2024 07:00 AM
RNS
Steriwave in British Columbia Health Authorities
06 Aug 2024 07:00 AM
RNS
Leeds Teaching Hospital NHS Trust to use Steriwave
28 Jun 2024 05:45 PM
RNS
Result of AGM and Voting Results
21 Jun 2024 07:00 AM
RNS
Steriwave now available through NHS Supply Chain
07 Jun 2024 07:00 AM
RNS
2023 Full Year Results and Annual Report
06 Jun 2024 07:00 AM
RNS
Notice of AGM and Directorate Change
28 May 2024 07:00 AM
RNS
Notice of Results, Investor Presentation, and AGM
13 May 2024 09:30 AM
RNS
NOTIFICATION OF MAJOR HOLDINGS
10 May 2024 07:00 AM
RNS
ECDC report shows rising HAIs and antibiotic use
08 May 2024 07:00 AM
RNS
Further Result of Fundraising
03 May 2024 04:27 PM
RNS
Result of Fundraising
03 May 2024 08:00 AM
RNS
Ondine announces proposed fundraising
02 May 2024 06:25 PM
RNS
Related Party Transactions
25 Apr 2024 07:00 AM
RNS
New study confirms nose is key source of infection
24 Apr 2024 07:00 AM
RNS
Corporate and Trading Update
22 Apr 2024 07:00 AM
RNS
Steriwave in first Australian hospital
15 Apr 2024 07:00 AM
RNS
32% Fewer SSIs After Steriwave Replaced Mupirocin
10 Apr 2024 07:00 AM
RNS
Steriwave authorized for use by HCA UK
04 Apr 2024 07:00 AM
RNS
Entry into ICU market expands revenue potential
28 Mar 2024 12:52 PM
RNS
Appointment of Interim Chief Financial Officer
25 Mar 2024 07:00 AM
RNS
First commercial adoption of Steriwave by the NHS
21 Mar 2024 07:00 AM
RNS
Steriwave study shows 77% drop in antibiotic use
15 Mar 2024 05:10 PM
RNS
Replacement: Steriwave deploying in 8 new sites
15 Mar 2024 07:00 AM
RNS
Steriwave deploying in eight new sites
05 Mar 2024 09:45 AM
RNS
Ondine starts first UK health economics study
31 Jan 2024 07:00 AM
RNS
Microbiome research supports use of Steriwave
26 Jan 2024 07:00 AM
RNS
Ondine unveils new research at SPIE Photonics West
26 Jan 2024 07:00 AM
RNS
Grant of Share Options
16 Jan 2024 08:15 AM
RNS
Appointment of new Chief Financial Officer
13 Dec 2023 07:00 AM
RNS
C$4.91 raise supports ongoing commercialisation
12 Dec 2023 01:20 PM
RNS
TR-1: NOTIFICATION OF MAJOR HOLDINGS
11 Dec 2023 06:15 PM
RNS
Result of Fundraising
05 Dec 2023 07:00 AM
RNS
Result of Placing & Broker Option Update
04 Dec 2023 01:28 PM
RNS
Close of Bookbuild
01 Dec 2023 06:13 PM
RNS
Update. Re investor-led financing
30 Nov 2023 06:40 PM
RNS
Ondine announces investor-led financing
16 Nov 2023 07:00 AM
RNS
Photodisinfection recommended as Standard of Care
31 Oct 2023 09:00 AM
RNS
Steriwave use expanded following successful pilot
23 Oct 2023 07:00 AM
RNS
66.5% reduction in spine surgery infection rate
18 Oct 2023 07:00 AM
RNS
Steriwave shown to reduce resistant bacteria

Ondine Biomedical is a Canadian life sciences company that develops light-activated antimicrobial therapies called photodisinfection to prevent and treat infections, including those from drug-resistant bacteria.

It is listed on LSE under the ticker OBI.

OBI share price launched at 59p in 2021.

UK 100

Latest directors dealings